Summit Therapeutics SMMT Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's earnings yield?
- Summit Therapeutics (SMMT) reported earnings yield of -8.2% in Q1 2026.
- How has Summit Therapeutics's earnings yield changed year-over-year?
- Summit Therapeutics's earnings yield decreased by 384.9% year-over-year, from -1.7% to -8.2%.
- What is the long-term trend for Summit Therapeutics's earnings yield?
- Over 5 years (2020 to 2025), Summit Therapeutics's earnings yield has grown at a 39.0% compound annual growth rate (CAGR), from -1.6% to -8.3%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.